GB584497A - Therapeutic preparations for intramuscular and subcutaneous injection and methods of making the same - Google Patents

Therapeutic preparations for intramuscular and subcutaneous injection and methods of making the same

Info

Publication number
GB584497A
GB584497A GB705744A GB705744A GB584497A GB 584497 A GB584497 A GB 584497A GB 705744 A GB705744 A GB 705744A GB 705744 A GB705744 A GB 705744A GB 584497 A GB584497 A GB 584497A
Authority
GB
United Kingdom
Prior art keywords
menstrum
proportions
excess
per cent
intramuscular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB705744A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WINIFRED MERCER PITKIN
Original Assignee
WINIFRED MERCER PITKIN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WINIFRED MERCER PITKIN filed Critical WINIFRED MERCER PITKIN
Priority to GB705744A priority Critical patent/GB584497A/en
Publication of GB584497A publication Critical patent/GB584497A/en
Expired legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A therapeutic preparation for intramuscular or subcutaneous injection is obtained by making a menstrum comprising sterile distilled water, gelatine in proportions in excess of 12-30 per cent., dextrose in proportions in excess of 5-12 per cent., and acetic acid in proportions in excess of 0.3-1.5 per cent., and then at a temperature of about 100 DEG F. adding to the menstrum a soluble injectible therapeutic agent and sufficient water to bring the composition within the above stated percentage ranges. Suitable therapeutic agents include one or more of the following: suprarenin, digitalis, ephedrine, adrin, morphine, pantophone, dilaudide, codeine, hyoscine hydrobromide, scopolamine, sodium barbital, pituitrin, antuitrin, pitressin, pitocin and heparin. Vasoconstrictors such as epinephrine hydrochloride and ephedrine sulphate and other additions such as eucupine and alcoholic chlorbutanol may also be included. Preferably the menstrum is made by first dissolving the gelatine in the water, subjecting the solution to vacuum, cooling and congealing the solution, again subjecting it to vacuum, dissolving the dextrose and acetic acid and boiling the mixture in vacuo. The preparation is preferably sealed in ampules in the absence of oxygen.
GB705744A 1944-04-17 1944-04-17 Therapeutic preparations for intramuscular and subcutaneous injection and methods of making the same Expired GB584497A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB705744A GB584497A (en) 1944-04-17 1944-04-17 Therapeutic preparations for intramuscular and subcutaneous injection and methods of making the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB705744A GB584497A (en) 1944-04-17 1944-04-17 Therapeutic preparations for intramuscular and subcutaneous injection and methods of making the same

Publications (1)

Publication Number Publication Date
GB584497A true GB584497A (en) 1947-01-16

Family

ID=9825799

Family Applications (1)

Application Number Title Priority Date Filing Date
GB705744A Expired GB584497A (en) 1944-04-17 1944-04-17 Therapeutic preparations for intramuscular and subcutaneous injection and methods of making the same

Country Status (1)

Country Link
GB (1) GB584497A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2126082A (en) * 1982-08-12 1984-03-21 Heinrich Schulze Pharmaceutical preparations having analgetic and cytostatic activity
US4536387A (en) * 1982-02-12 1985-08-20 Unitika Ltd. Anti-cancer device
EP1585519A1 (en) * 2002-11-25 2005-10-19 Durect Corporation High concentration formulations of opioids and opioid derivatives

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536387A (en) * 1982-02-12 1985-08-20 Unitika Ltd. Anti-cancer device
US4642111A (en) * 1982-02-12 1987-02-10 Unitika Ltd. Injector filled with an anti-cancer composition
GB2126082A (en) * 1982-08-12 1984-03-21 Heinrich Schulze Pharmaceutical preparations having analgetic and cytostatic activity
EP1585519A1 (en) * 2002-11-25 2005-10-19 Durect Corporation High concentration formulations of opioids and opioid derivatives
EP1585519A4 (en) * 2002-11-25 2009-09-23 Durect Corp High concentration formulations of opioids and opioid derivatives

Similar Documents

Publication Publication Date Title
US3868358A (en) Protamine-insulin product
Mergenhagen et al. Preparation and biological activities of endotoxins from oral bacteria
US3758683A (en) Insulin product
US3070623A (en) Pharmacological compounds
GB584497A (en) Therapeutic preparations for intramuscular and subcutaneous injection and methods of making the same
Keen et al. Dermatonecrotic properties of extracts from the tentacles of the cnidarian Chironex fleckeri
Cohen et al. Detection of luteotropic and mammotropic activity in the serum of rats at midpregnancy
Davies et al. Observations on the preparation, properties and source of the parathyroid hormone. Part I
Soda et al. On a new sulphuric acid ester in the mucus of Charonia lampas
US2574889A (en) Methylated gelatin-insulin preparation
Wood et al. STUDIES ON THE Cx-REACTIVE PROTEIN: I. The Effect of Administration of Cx-Reactive Protein to Normal Rabbits
GB642380A (en) Improvements in method of making therapeutic preparations for subcutaneous or intramuscular injections
ES257899A1 (en) Improvements in or relating to process for the manufacture of therapeutic useful preparations of iron
US2766175A (en) Mersalyl diuretic solutions stabilized with methylated glycines
GB322170A (en) Improved process for the production of durable solutions of suprarenal preparations mixed with an?sthetics
GB420529A (en) Improvements in and relating to the manufacture of cellulose esters
GB591027A (en) 11-amino-undecyclic acid and its method of preparation
GB444626A (en) Improvements in and relating to methods of producing artificial cellulosic products containing nitrogen
US2143829A (en) Water soluble derivative of p-aminobenzenesulphonamide
GB659053A (en) Process for the preparation of a transparent gel-like tooth paste, and tooth paste produced according to this process
Salmi et al. Inhibition of Uterine β-Glucuronidase Activity in the Rat by Local Application of Potassium Hydrogen Saccharate
Baranger et al. The action on avian malaria of the alkaloids of cinchonas from the Cameroons and the Belgian Congo
GB720166A (en) Method of preparing the tri-p-aminosalicylate of dihydrostreptomycin
ASAMI et al. EFFECT OF TWEEN 80 ON THE TUBERCULIN REACTION 1. Tuberculin Reaction in Guinea Pigs Caused by the PPDs Added with Tween 80
GB562009A (en) Tetraethylthiuram monosulphide preparations